These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26507831)

  • 1. Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers.
    Yardley MM; Mirbaba MM; Ray LA
    CNS Drugs; 2015; 29(10):833-45. PubMed ID: 26507831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Varenicline and Nicotine Replacement Therapy for Smoking Cessation in Older and Younger Smokers: A Prospective Cohort in Taiwan.
    Chang PY; Shiu MN; Yuan YT; Chang HC; Su PY; Lan TH
    Nicotine Tob Res; 2019 Jan; 21(2):149-155. PubMed ID: 29294121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking.
    Fridberg DJ; Cao D; Grant JE; King AC
    Alcohol Clin Exp Res; 2014 Oct; 38(10):2622-9. PubMed ID: 25335648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review.
    Leeman RF; Huffman CJ; O'Malley SS
    Alcohol Alcohol; 2007; 42(3):196-206. PubMed ID: 17526629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for Personalized Medicine for Binge Drinking Smokers: Smoking Cessation Using Varenicline, Nicotine Patch, or Combination Nicotine Replacement Therapy.
    Kaye JT; Johnson AL; Baker TB; Piper ME; Cook JW
    J Stud Alcohol Drugs; 2020 Jul; 81(4):426-435. PubMed ID: 32800078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescribing Prevalence, Effectiveness, and Mental Health Safety of Smoking Cessation Medicines in Patients With Mental Disorders.
    Taylor GMJ; Itani T; Thomas KH; Rai D; Jones T; Windmeijer F; Martin RM; Munafò MR; Davies NM; Taylor AE
    Nicotine Tob Res; 2020 Jan; 22(1):48-57. PubMed ID: 31289809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings.
    Ray LA; Courtney KE; Ghahremani DG; Miotto K; Brody A; London ED
    Psychopharmacology (Berl); 2014 Oct; 231(19):3843-53. PubMed ID: 24733235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily: A Randomized Clinical Trial.
    King A; Vena A; de Wit H; Grant JE; Cao D
    JAMA Netw Open; 2022 Mar; 5(3):e220951. PubMed ID: 35244704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Alcohol Consumption During a Stop-Smoking Attempt and Differences Between Smokers Using Nicotine Replacement and Smokers Using Varenicline.
    Przulj D; Hajek P; Snuggs S; McRobbie H
    Nicotine Tob Res; 2018 Apr; 20(5):583-588. PubMed ID: 28521015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement.
    Martin RA; Rohsenow DJ; Tidey JW
    J Subst Abuse Treat; 2019 Sep; 104():22-27. PubMed ID: 31370981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.
    Hurt RT; Ebbert JO; Croghan IT; Schroeder DR; Hurt RD; Hays JT
    Drug Alcohol Depend; 2018 Mar; 184():12-17. PubMed ID: 29324248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment.
    Kahler CW; Cioe PA; Tzilos GK; Spillane NS; Leggio L; Ramsey SE; Brown RA; O'Malley SS
    Alcohol Clin Exp Res; 2017 Jun; 41(6):1201-1211. PubMed ID: 28401564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking.
    Gómez-Coronado N; Walker AJ; Berk M; Dodd S
    Pharmacotherapy; 2018 Feb; 38(2):235-258. PubMed ID: 29250815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
    Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
    Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.
    Roberts E; Eden Evins A; McNeill A; Robson D
    Addiction; 2016 Apr; 111(4):599-612. PubMed ID: 26594837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
    Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G
    Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of nicotine deprivation and indices of alcohol use behavior to implicit alcohol and cigarette approach cognitions in smokers.
    Cohn A; Ehlke S; Cobb CO
    Addict Behav; 2017 Apr; 67():58-65. PubMed ID: 28038363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
    Cahill K; Stevens S; Perera R; Lancaster T
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions to increase adherence to medications for tobacco dependence.
    Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.